ArticleFrontiers in pharmacology2025

Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.

Chen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.